Cart
sales@molnova.com
PI3Kδ-IN-2
CAS No. 1702816-75-8
PI3Kδ-IN-2( —— )
Catalog No. M20551 CAS No. 1702816-75-8
PI3Kδ-IN-2 is a potent and selective inhibitor of PI3Kδ .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 36 | In Stock |
|
| 5MG | 58 | In Stock |
|
| 10MG | 87 | In Stock |
|
| 25MG | 192 | In Stock |
|
| 50MG | 295 | In Stock |
|
| 100MG | 462 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
| 1 mL x 10 mM in DMSO | 80 | In Stock |
|
| 2MG | 38 | In Stock |
|
| 5MG | 61 | In Stock |
|
| 10MG | 92 | In Stock |
|
| 25MG | 202 | In Stock |
|
| 50MG | 305 | In Stock |
|
| 100MG | 477 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePI3Kδ-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionPI3Kδ-IN-2 is a potent and selective inhibitor of PI3Kδ .
-
DescriptionPI3Kδ-IN-2 is a potent and selective inhibitor of PI3Kδ.(In Vitro):Linperlisib (YY-20394) is under the study for the recurrent and/or refractory follicular lymphoma.
-
In VitroLinperlisib (YY-20394) is under the study for the recurrent and/or refractory follicular lymphoma.
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPI3Kδ
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1702816-75-8
-
Formula Weight588.69
-
Molecular FormulaC28H37FN6O5S
-
Purity>98% (HPLC)
-
SolubilityDMSO:25 mg/mL (42.47 mM)
-
SMILESCOc1ncc(cc1NS(C)(=O)=O)-c1nc(nc2c(CN3CCC(CC3)C(C)(C)O)cc(F)cc12)N1CCOCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Vps34-IN-1
Vps34-IN-1 is a potent, selective inhibitor of class III PI3K Vps34 with IC50 of 25 nM.
-
PKI-402
A potent dual PI3K/mTOR inhibitor.
-
PI3Kα-IN-4h
PI3Kα-IN-1 is a potent, selective, ATP-competitive dual PI3Kα/mTOR inhibitor with IC50 of 0.5/104 nM respectively.
